FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Chiang Richard

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/3/2013 

3. Issuer Name and Ticker or Trading Symbol

BIOADAPTIVES, INC. [BDPT]

(Last)        (First)        (Middle)

460 BRANNAN STREET SUITE 78064

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                            ___ X ___ 10% Owner
___ X ___ Officer (give title below)          ___ X ___ Other (specify below)
President,Secretary,Treasurer / *Resigned positions on 6/20/13

(Street)

SAN FRANCISCO, CA 94107       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   (1) (2) 10000000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  On April 19, 2013, the Registrant issued Richard Chiang 10,000,000 shares stock in exchange for incorporation fees and annual resident agent fees in the State of Delaware, and developing its business concept and plan.
( 2)  On June 20, 2013, the Registrant accepted the resignations of Richard Chiang as the Registrant's President, Secretary, Treasurer.

Remarks:
On July 3, 2013, a Form 4 disclosing the sale of the Registrant's shares was filed on Edgar. This Form 3 filing was made to disclose the initial ownership disclosure to the July 3, 2013 Form 4 filing disclosure. Ownership disclosure of the shares were also made on the initial Form 10 filed May 3, 2013.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Chiang Richard
460 BRANNAN STREET SUITE 78064
SAN FRANCISCO, CA 94107 		X X President,Secretary,Treasurer *Resigned positions on 6/20/13

Signatures
Richard Chiang 1/5/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Grafico Azioni Bioadaptives (PK) (USOTC:BDPT)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Bioadaptives (PK)
Grafico Azioni Bioadaptives (PK) (USOTC:BDPT)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Bioadaptives (PK)